| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |